Since 2013, MIU Men's Health Foundation has allocated a yearly scholarship - the Jeff Murri Award - in the amount of $1,000 to students focusing their studies on men’s health. 

The award is named in posthumous honor of Jeff Murri, the well-respected vice president and general manager of WJBK-TV FOX 2 Detroit.

Please consider making a donation to the Jeff Murri Scholarship Fund in memory of Jeff Murri. 

How to apply

This opportunity is open to students:

  • Enrolled at Central Michigan University College of Medicine, Michigan Medical School (University of Michigan at Ann Arbor), Michigan State University College of Human or Osteopathic Medicine, Oakland University William Beaumont School of Medicine, or Wayne State School of Medicine.

  • Enrolled as an M1, M2 or M3 student in good academic standing at the schools listed above.

  • Prepared to start a research project focusing on men's health in the Spring of 2019.

Electronic submission of all application materials is required. All application materials must be received no later than 5pm Eastern Time, May 31, 2019. Applicants will be selected based upon their strength of argument for participation. All applicants will be notified of the selection decision by June 5, 2019. 


2018 Award Recipient

Zoë Indigo Smith | M2 | Class of 2020 | Detroit, Michigan

This study will explore the connection between skin cancer and prostate cancer to promote screening and early detection in underserved populations.

2017 Award Recipient

Brandon Nguyen | M2 | Class of 2019 | Fountain Valley, California

This study will investigate the rate of toxicity to the rectum and urethra from high-dose brachytherapy and dosing parameters with respect to gastrointestinal and genitourinary toxicity.

2016 Award Recipient

Amandeep Sawana | M1 | Class of 2020 | Brampton, Ontario

This study will investigate the feasibility, safety, comfort to patient and common outcomes of using suprapubic catheters over Foley catheters following robotic salvage prostatectomies.

2015 Award Recipients

Kassem Faraj | M2 | Class of 2017 | Dearborn, Michigan

This study will compare the outcomes of open vs. robotic retroperitoneal lymph node dissection (RPLND) as treatments for nonseminomatous testicular germ cell tumors.


Dylan Eugene Greeney | M2 | Class of 2017 | Herrin, Illinois

This study will look to potentially decrease morbidity and mortality from melanoma and non-melanoma skin cancer among men by determining which methods of sun protection measures will increase compliance of usage, decreasing UV exposure.


Robert Petrossian | M2 | Class of 2017 | Reston, Virginia

This study aims to explore the presentation and treatment associated with urinary tract stone care along with evaluating the relationship between initial management, length of stay and costs, possibly generating a standardized clinical approach.


Michael E. Rezaee | M2 | Class of 2017 | Derry, New Hampshire

This study will evaluate prostate cancer screening practices (PSA, ultrasound, biopsy) as well as the incidence of prostate cancer diagnoses before and after the USPTF recommended against yearly PSA screening in men over 50 years of age in May, 2012. 


Anthony Turk | M2 | Class of 2017 | Lake Forest, California

This study will investigate which therapies are most effective in reducing bone pain from prostate cancer so that future patients diagnosed with metastatic prostate cancer can achieve maximal pain relief, mobility and quality of life. 

2014 Award Recipients

Grenville Fernandes | M2 | Class of 2016 | Bloomington, Illinois

This project will examine data from both 2012 & 2013 Men’s Health Events, exploring possible relationship between race, high cholesterol, and prostate cancer.


Jonathan Hung | M1 | Class of 2017 | East Brunswick, New Jersey

This project will explore if the response to primary androgen deprivation therapy (ADT) can predict the response to subsequent novel ADT in metastatic prostate cancer patients.


Thanh Huynh | M1 | Class of 2017 | Hayward, California

This study will explore whether the results of new epigenetic assays (such as ConfirmMDX) can decrease the frequency of follow-up visits or repeat prostate biopsies.


Danny Mammo| M2 | Class of 2016 | West Bloomfield, Michigan

This project will look at the development of an organized post-radical prostatectomy pelvic floor rehabilitation program guided by identification of high-risk patients through urine loss ratio measurement after catheter removal.


Jenna Millstead| M1 | Class of 2017 | Farmington Hills, Michigan

Little is known about gender specific differences in attitude, knowledge, and perceptions of genetic counseling and testing by male BRCA mutation carriers. This research seeks to elucidate those differences in an attempt to understand how to better educate men about BRCA mutations and ultimately to improve compliance with screening and prevention recommendations.

2013 Award Recipients

Christopher Jaeger | M2 | Class of 2015 | Royal Oak, Michigan

Assessing changes in penile sensory function and erectile function as a result of robotic assisted radical prostatectomy, indirectly measuring the functional ability of the cavernous nerve.


Grenville Fernandes | M1 | Class of 2016 | Bloomington, Illinois

Examining data from upcoming 2013 Men’s Health Event, and help reveal areas in which to better educate the community.